Docencia

Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study (09/01/2023)

Dr. Oskar Ayerdi Aguirrebengoa
Centro Sanitario Sandoval, IdISSC.
Hospital Clínico San Carlos, Madrid.

Stable Latent HIV Infection and Low level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat (09/12/2022)

Dra. Verónica Briz
Centro Nacional de Microbiología.
Instituto de Salud Carlos III.

Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention (25/11/2022)

Dra. Isabel A. Pérez Hernández
Unidad de Enfermedades Infecciosas
Hospital Universitario Virgen de la Victoria, Málaga.

Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer (11/11/2022)

Dr. Boris Revollo
Germans Trias i Pujol University Hospital.
Infectious Diseases Department. Fight Infections Foundation.

Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium (28/10/2022)

Helena Albendín Iglesias
Hospital Clínico Universitario Virgen de la Arrixaca.

Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection (14/10/2022)

Dra. Miriam Estébanez Muñoz
Sección Enfermedades Infecciosas.
Medicina Interna Hospital Universitario “Gómez Ulla”, Madrid.

Two randomized trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition (17/06/2022)

Dra. Beatriz Mothe Pujadas
Servicio Enfermedades Infecciosas, IrsiCaixa
Hospital Germans Trias i Pujol, Badalona

Outcomes of people living with HIV after hospital discharge: a systematic review and meta-analysis. Nathan Ford et al. Lancet HIV 2022; 9: e150–59 (03/06/2022)

Dr. Carlos Dueñas Gutiérrez
Hospital Clínico Universitario de Valladolid.

Single-Dose Liposomal Amphotericin B Treatment for Ctyptococcal Meningitis (20/05/2022)

Dra. Rocío Montejano
Hospital Universitario La Paz, Madrid.

Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies. Li JZ, et al. Clin Infect Dis 2022; 74: 865-70 (22/04/2022)

Juan Emilio Losa
Hospital Universitario Fundación Alcorcón

Factors associated with low levels of HIV testing among young men who have sex with men (MSM) participating in EMIS-2017 in Spain (08/04/2022).

Inmaculada Jarrín
Centro Nacional de Epidemiología, Instituto de Salud Carlos III

HCV reinfection after HCV therapy among HIV/HCV coinfected individuals in Europe. Amele S and the EuroSIDA study group. HIV Medicine 2021;00:1–9 (18/03/2022).

Dr. Carlos Dueñas Gutiérrez
Hospital Clínico Universitario de Valladolid.

Coronary Artery Disease–Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study (18/02/2022)

Dra. Rocío Montejano
Hospital Universitario La Paz, Madrid

Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study. (04/02/2022)

Dr. Juan Emilio Losa
Hospital Universitario Fundación Alcorcón, Madrid

Associations of Hepatosteatosis with cardiovascular disease in HIV-Positive and HIV-Negative patients: The Liverpool HIV-Heart Project (21/01/2022)

Dr. Sergio Reus Pujadas
Hospital General Universitario de Alicante.

Quality of life in people living with HIV in Romania and Spain (10/01/2022)

Dra. Inmaculada Jarrín
Centro Nacional de Epidemiología, Instituto de Salud Carlos III.

A Possible Sterilizing Cure of HIV-1 Infection Without Stem Cell Transplantation (20/12/2021)

Dra. Beatriz Mothe Pujadas
IrsiCaixa, Servicio Enfermedades Infecciosas
Hospital Germans Trias i Pujol, Badalona.

Prevalence of Gastrointestinal Pathogens Detected by Multiplex Polymerase Chain Reaction in a Prospective Cohort of Men Who Have Sex With Men Taking Human Immunodeficiency Virus Preexposure Prophylaxis—New York City, 2019–2020 (10-12-2021)

Dr. Carlos Dueñas
Hospital Clínico Universitario de Valladolid.

No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/microlitre (26-11-2021)

Dra. Rocio Montejano
Hospital Universitario La Paz, Madrid.

Página 1 de 812345678

Accesos directos